Since the effect of tasquinimod treatment was a change from F480+CD206+ to F4/80+CD206− macrophages without changing the total frequency of F4/80+ cells, this would require a rapid turnover of macrophages in the tumor to explain the treatment effects. The gene discussed is MRC1; the disease is neoplasm.